Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alexandra N. Carey"'
Autor:
Katherine Culbreath, MD, Gregory Keefe, MD, Emily Nes, MD, Jamie Knell, MD, Sam M. Han, MD, Priyanka Chugh, MD, Grace Y. Han, BS, Alexandra N. Carey, MD, Lissette Jimenez, MD MPH, Jay R. Thiagarajah, MD PhD, Sung-Yun Pai, MD, Biren P. Modi, MD MPH, Tom Jaksic, MD PhD
Publikováno v:
Journal of Pediatric Surgery Case Reports, Vol 80, Iss , Pp 102247- (2022)
Mutations in the tetratricopeptide repeat domain 7A (TTC7A) gene are associated with severe intestinal disorders and combined immunodeficiency (CID), with poor long-term survival. This study describes the characteristics and clinical course of six pa
Externí odkaz:
https://doaj.org/article/ac3ccdf5645d48cf947a7fbd7063ea1b
Autor:
Gregory Keefe, Katherine Culbreath, Steven J. Staffa, Alexandra N. Carey, Tom Jaksic, Riten Kumar, Biren P. Modi
Publikováno v:
The Journal of Pediatrics. 253:152-157
To quantify the rate of venous thromboembolism (VTE) in patients with pediatric intestinal failure and identify associated risk factors.We performed a retrospective cohort study in pediatric patients (21 years old) with severe pediatric intestinal fa
Autor:
Katherine Culbreath, Gregory Keefe, Emily Nes, Steven J. Staffa, Alexandra N. Carey, Tom Jaksic, Jeffrey D. Goldsmith, Biren P. Modi, Jodie D. Ouahed, Lissette Jimenez
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 76:468-474
Publikováno v:
Current Opinion in Clinical Nutrition & Metabolic Care. 26:201-209
Autor:
Katherine Culbreath, Jamie Knell, Gregory Keefe, Sam M. Han, Charles R. Hong, Heather B. Riley, Enju Liu, Alexander J. McAdam, Biren P. Modi, Tom Jaksic, Christopher P. Duggan, Alexandra N. Carey
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 75(3)
To evaluate symptoms, enteral tolerance, growth, and antibiotic regimens in pediatric intestinal failure (IF) patients after treated with antibiotic therapy for small bowel bacterial overgrowth (SBBO).Single-center retrospective review of children 0-
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 72:451-455
Background Composite lipid emulsion (CLE) composed of soybean oil, medium-chain triglycerides, olive oil, and fish oil is approved in the US for parenterally fed adults. For stable children discharged on home parenteral nutrition (HPN) without choles
Autor:
Melissa Takvorian-Bené, Mary Gallotto, Bram P. Raphael, Alexandra N. Carey, Christina Tascione, Carolyn Rosa, Jennifer McClelland
Publikováno v:
Journal of Infusion Nursing. 42:132-136
To maximize safety and the patient experience, caregivers require intensive training to administer home parenteral nutrition (HPN) before initial hospital discharge. This article provides the rationale, best practices, and a template for caregiver pr
Autor:
Simon Lam, Celine S. Lages, Amy Taylor, Julia Simmons, Rebekah Karns, Claire A. Chougnet, Ramesh Kudira, Maha Almanan, Alexander Miethke, Kumar Shanmukhappa, Tiffany Shi, Alexandra N. Carey
Publikováno v:
Hepatology. 68:1905-1921
In the multidrug resistance protein 2 (Mdr2)-/- mouse model, low phospholipid bile instigates biliary epithelial injury, sterile inflammation, and fibrosis, thereby recapitulating disease mechanisms implicated in biliary atresia (BA) and primary scle
Autor:
Bram P. Raphael, Alexandra N. Carey, Mark Puder, Coral Rudie, Kathleen M. Gura, Paul Mitchell
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 43:305-310
Infants requiring prolonged parenteral nutrition (PN) may receive intravenous (IV) lipid in the form of soybean oil, fish oil, or a composite lipid emulsion (CLE) (i.e., SMOFlipid®). Soybean oil lipid-dose restriction is a popular method of treating
Autor:
Bram P. Raphael, Christopher Duggan, Christina Tascione, Kathleen M. Gura, Margaret K. Murphy, Alexandra N. Carey
Publikováno v:
Nutrition in Clinical Practice. 32:820-825
Home parenteral nutrition (HPN) and home intravenous (IV) hydration are complex, high-risk life-sustaining therapies for children and adults with severe digestive disorders. HPN compounding errors have the potential to cause serious patient harm. Her